Genetic Determinants and Potential Therapeutic Targets for Pancreatic Adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer deaths in both men and women in the United States, carrying a 5-year survival rate of approximately 5%, which is the poorest prognosis of any solid tumor type. Given the dismal prognosis associated with PDAC, a more thoro...
| Autores principales: | , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014-03-01
|
| Colección: | Frontiers in Physiology |
| Materias: | |
| Acceso en línea: | http://journal.frontiersin.org/Journal/10.3389/fphys.2014.00087/full |